Condition
Localized Scleroderma
Total Trials
6
Recruiting
0
Active
0
Completed
4
Success Rate
80.0%-7% vs avg
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
80.0%
-6.6% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results80% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
Early P 1 (1)
P 2 (1)
Trial Status
Completed4
Terminated1
Unknown1
Trial Success Rate
80.0%
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT06646146Not ApplicableCompleted
Study on the Efficacy of Autologous Fat Grafting in Improving Hair Transplantation Outcomes for Patients With Localized Scleroderma-Related Alopecia
NCT06621628Not ApplicableCompletedPrimary
Photobiomodulation in Children With Localized Scleroderma
NCT04200755Phase 2CompletedPrimary
Clinical Trial to Evaluate Efficacy and Safety of Dupilumab in Localized Scleroderma
NCT02411643Early Phase 1Terminated
Molecular Effects of Topical Calcipotriene on Morphea
NCT01697254Completed
The CARRA Registry
NCT02002897Not ApplicableUnknownPrimary
Fractional Carbon Dioxide Laser Versus UVA 1 in Treatment of Localized Scleroderma
Showing all 6 trials